EMVision emu™ Brain Scanner for Detecting Stroke

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

Recruiting Observational Study
Stroke Hemorrhagic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
EMVision Medical Devices Ltd · Research network
Who this trial is looking for

This trial is looking for adults suspected of having a stroke. Participants will undergo a scan with a new device designed to quickly detect bleeding in the brain.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult aged 22 or older
  • I have symptoms that suggest a stroke
  • My symptoms started within the last 24 hours
  • I can have a CT or MRI scan after the EMVision scan
  • My head size is suitable for the EMVision scan

You may not be able to join if

  • I have received treatment for a stroke before the scans
  • I was in the hospital for a neurological condition before my stroke symptoms
  • I was in intensive care before my stroke symptoms
  • I have a condition that makes neuroimaging unsafe
  • I have any electro-stimulating devices in my head or neck
  • I have metallic implants in my skull or nearby areas
  • I cannot wear the EMVision device due to scalp issues or injuries
  • I am pregnant or breastfeeding

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this research is to evaluate a new investigational device for the diagnosis of stroke, the EMVision emu™ Brain Scanner. Stroke is the result of a blood clot stopping the normal flow of blood in the brain (ischaemic stroke) or a breakage in a blood vessel causing bleeding in the brain (haemorrhagic stroke). Stroke is a medical emergency and must be quickly diagnosed and treated. Comp…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Adults ≥22 years of age 2. Observable acute neurological deficit suspected to be stroke and within 24 hours of symptom onset 3. The use of the EMVision emu™ Brain Scanner will not delay the treatment of the patient 4. CT or MRI brain imaging following clinical evaluation per …
Contacts

Christian Wight, PhD

61 (0) 490 109 797

cwight@emvision.com.au

CONTACT

Sadie Burnham

7742078910

sburnham@vastrax.com

CONTACT